Restructuring and underlying growth boost Evotec's second quarter
07 August 2009
Sita Shah
Please Login to read the full article.
07 August 2009
Sita Shah
sita.shah@informa.com
Evotec's second-quarter revenues grew by 46% to €10.5 million and its net loss decreased by 29% to €8.6 million following strong underlying growth and significant cost cutting.
It has implemented a major restructuring programme to reduce operating costs and maintain liquidity beyond...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Oncology growth drives an otherwise lacklustre Japanese market
- Forma strikes discovery deal with Janssen in cancer metabolism, worth up to $700M
- Progenics to narrow focus to oncology, cut staff by 26%
- Roche and Evotec end depression alliance as Phase II trial proves 'too difficult'
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
